ARTICLE | Company News
CHMP backs Boehringer's afatinib
July 27, 2013 12:43 AM UTC
EMA's CHMP on Friday backed approval of an MAA from Boehringer Ingelheim GmbH (Ingelheim, Germany) for Giotrif afatinib to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) with ...